In search for genetic determinants of clinically meaningful differential cardiovascular event reduction by pravastatin in the PHArmacogenetic study of Statins in the Elderly at risk (PHASE)/PROSPER study

Author(s):
Postmus, I.; Johnson, P.C.D.; Trompet, S.; Craen, A.J.M. de (0000-0001-9314-123X); Slagboom, P.E.; Devlin, J.J.; Shiffman, D.; Sacks, F.M.; Kearney, P.M.; Stott, D.J.; Buckley, B.M.; Sattar, N.; Ford, I.; Westendorp, R.G.J. (0000-0002-0672-8372); Jukema, J.W. (0000-0002-3246-8359)
Published
2014
Publication type
Article / Letter to editor
PharmacogeneticsStatinsGWASCardiovascular diseases
Date issued
2014-07-31
Language
English
Is part of
hdl
1887/103352
doi
10.1016/j.atherosclerosis.2014.04.009